News
A shower is a relatively simple routine that usually doesn’t require 10 steps or a plethora of products. A daily shower with ...
Monthly weight-loss shots on the horizon! Learn about new drugs like MariTide and why Black participation in clinical trials ...
This segment is sponsored by Eli Lilly and Company.Social media is flooded with advertisments for popular obestiy medications ...
TOKYO-Nintendo's new Switch 2 videogame machine uses a rare-earth magnet to attach its hand-held controllers to the main console, according to a teardown, highlighting the company's vulnerability to ...
The drugmaker has become a clear winner with its weight-loss drugs. Now, with a pill under development, the company should ...
Eli Lilly reported impressive data at the recent American Diabetes Association ('ADA') conference. Its robust pipeline will ...
Obesity medications, once facing shortages, are now widely available. So how do consumers not get scammed into purchasing ...
Adults with obesity were more likely to achieve a 10% or greater weight loss at 1 year if they continued using their ...
Eli Lilly (LLY 0.40%) and Novo Nordisk (NVO 1.97%) are two phenomenal growth stocks that investors probably can't go wrong ...
The weight-loss drug boom has dominated headlines for the last two years — but underneath the hype lies a major flaw in the ...
Eli Lilly's Mounjaro saw a dramatic increase in sales, with numbers doubling in just a month. Novo Nordisk, on the other hand, has taken a significant step by submitting a higher dose of its obesity ...
A GLP-1/glucagon dual agonist conferred weight loss of up to 12.55% at 32 weeks for adults with overweight or obesity, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results